000 01391 a2200433 4500
005 20250514071127.0
264 0 _c20030721
008 200307s 0 0 eng d
022 _a0927-3948
024 7 _a10.1076/ocii.10.3.201.15599
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBanta, James T
245 0 0 _aPresumed toxoplasmosic anterior optic neuropathy.
_h[electronic resource]
260 _bOcular immunology and inflammation
_cSep 2002
300 _a201-11 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAnimals
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOptic Disk
_xparasitology
650 0 4 _aOptic Nerve Diseases
_xclassification
650 0 4 _aPrednisone
_xtherapeutic use
650 0 4 _aPyrimethamine
_xtherapeutic use
650 0 4 _aRetrospective Studies
650 0 4 _aSulfadiazine
_xtherapeutic use
650 0 4 _aToxoplasmosis, Ocular
_xclassification
650 0 4 _aVisual Acuity
700 1 _aDavis, Janet L
700 1 _aLam, Byron L
773 0 _tOcular immunology and inflammation
_gvol. 10
_gno. 3
_gp. 201-11
856 4 0 _uhttps://doi.org/10.1076/ocii.10.3.201.15599
_zAvailable from publisher's website
999 _c12574791
_d12574791